Stocks React To February Jobs Report: The Winners And Losers
The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors.
Why Assertio Therapeutics Shares Are Trading Higher Today
Assertio Therapeutics (NASDAQ: ASRT) shares are trading higher on Thursday after the company reported better-than-expected Q4 sales results.
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Assertio Announces Partnership With The Lennox-Gastaut Syndrome Foundation
SYMPAZAN® (clobazam) oral film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and older
Oral film delivery from SYMPAZAN® delivers
UPDATE: Assertio Therapeutics Q3 Adj. EPS $0.22 Beats $0.07 Estimate
Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
